Abbott reaches $23 billion deal to buy Exact Sciences
Illinois-based Abbott has inked a definitive agreement to buy Exact Sciences, the Madison-headquartered cancer detection company, in a deal valued at $23 billion.
To access this content, you must purchase a Premium membership, or log in if you are a member.
